Securian Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Securian Asset Management's JAZZ Position: Q2 2026 in Review
Securian Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 4.1% in Q2 2026, buying an estimated $40.3K and bringing the position to 4,627 shares worth $1.15M. The position accounts for 0.04% of the portfolio, ranked #311.
Securian Asset Management first reported a position in JAZZ in Q3 2020 and has held it in 24 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Securian Asset Management held 4,627 shares of Jazz Pharmaceuticals worth $1.15M as of Q2 2026.
- Securian Asset Management bought 184 Jazz Pharmaceuticals shares in Q2 2026, an estimated $40.3K.
- Jazz Pharmaceuticals made up 0.04% of Securian Asset Management's portfolio in Q2 2026, its #311 holding.
- Securian Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.